PREVALENCE OF CYP2D6*4 AND ITS POSSIBLE RELATION TO THERAPEUTIC OUTCOMES OF ADJUVANT TAMOXIFEN THERAPY IN EGYPTIAN PREMENOPAUSAL WOMEN WITH BREAST CANCER

Background: Although tamoxifen is a main adjuvant therapy in estrogen positive breast cancer especially in premenopausal women, reliance on genetic polymorphisms of its CYP2D6 metabolizing enzyme and/or therapeutic drug monitoring of its active metabolite, endoxifen to determine tamoxifen-therapeuti...

Cijeli opis

Bibliografski detalji

Glavni autori:	Mohammad Hareedy, Amira Taha, Mohamed Abdelrady, Medhat Saleh, Ehab EL Desoky, Abeer Ibrahim
Format:	Artigo
Jezik:	Inglês
Izdano:	Assiut University, Faculty of Pharmacy 2022-12-01
Serija:	Bulletin of Pharmaceutical Sciences. Assiut University
Teme:	Tamoxifen CYP2D6*4 premenopausal Egyptian females breast cancer
Online pristup:	https://bpsa.journals.ekb.eg/article_271774_f1d862a6c0e55099240a99ff96680234.pdf
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!